Cargando…
Nucleocapsid as a next-generation COVID-19 vaccine candidate
Multiple new variants of the SARS-CoV-2 virus have emerged globally, due to viral mutation. The majority of COVID-19 vaccines contain SARS-CoV-2 spike protein, which is susceptible to mutation. It is known that protection against COVID-19 after two doses of mRNA vaccine continuously wanes over time....
Autores principales: | Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Hedjran, Farah, Sanchez, Ana, Prokopenko, Elena, Reid, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250828/ https://www.ncbi.nlm.nih.gov/pubmed/35788417 http://dx.doi.org/10.1016/j.ijid.2022.06.046 |
Ejemplares similares
-
Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
por: Oronsky, Bryan, et al.
Publicado: (2022) -
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making
por: Larson, Christopher, et al.
Publicado: (2020) -
Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2022) -
What Exactly Is Inflammation (and What Is It Not?) †
por: Oronsky, Bryan, et al.
Publicado: (2022) -
A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
por: Oronsky, Bryan, et al.
Publicado: (2021)